Screen all rheumatology patients for hepatitis: Gane


All rheumatology patients should be screened for hepatitis B before starting long-term immunosuppressive treatment, the conference has heard. Speaking at a plenary session on hepatology for rheumatologists Professor Ed Gane, Chief hepatologist at Auckland City Hospitals Liver Transplant Unit told delegates there were currently 500,000 people in Australia living with chronic viral hepatitis and many ...


Already a member? Login to keep reading


OR
© 2017 the limbic